Organosyn Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
as on 14-12-2024
- Paid Up Capital ₹ 9.70 Cr
as on 14-12-2024
- Company Age 13 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -36.41%
(FY 2020)
- Profit -29.19%
(FY 2020)
- Ebitda -18.80%
(FY 2020)
- Net Worth 6.46%
(FY 2020)
- Total Assets 37.94%
(FY 2020)
About Organosyn Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 20.00 Cr and a paid-up capital of Rs 9.70 Cr, as per Ministry of Corporate Affairs (MCA) records.
Manav Jassal and Sat Jassal serve as directors at the Company.
- CIN/LLPIN
U24100TG2011PTC150729
- Company No.
223635
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Aug 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Organosyn Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manav Jassal  | Director | 29-Dec-2012 | Current |
| Sat Jassal | Director | 08-Jun-2016 | Current |
Financial Performance and Corporate Structure Insights of Organosyn Life Sciences.
Organosyn Life Sciences Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 36.41% decrease. The company also saw a substantial fall in profitability, with a 29.19% decrease in profit. The company's net worth moved up by a moderate rise of 6.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Organosyn Life Sciences?
In 2020, Organosyn Life Sciences had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Evertogen Life Sciences LimitedActive 11 years 11 monthsManav Jassal and Sat Jassal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Organosyn Life Sciences?
Unlock and access historical data on people associated with Organosyn Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Organosyn Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Organosyn Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
